BIONORICA
LIVE

Serial Number

79070126

Owner

BIONORICA AG

Attorney

Kenneth F. Florek

Filing Date

Mar 26, 2009

Add to watchlist:

No watchlists yet
View on USPTO

BIONORICA Trademark

Serial Number: 79070126 • Registration: 3870253

BIONORICA is a trademark filed by BIONORICA AG on March 26, 2009. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

BIONORICA AG (65 trademarks)

KERSCHENSTEINERSTRASSE 11-15
92318 NEUMARKT , DE

Entity Type: 09

BIONORICA SE (41 trademarks)

KERSCHENSTEINERSTRAßE 11-15
NEUMARKT 92318 , DE

Entity Type: 94

Trademark Details

Filing Date

March 26, 2009

Registration Date

November 2, 2010

Published for Opposition

August 17, 2010

Goods & Services

Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of [ gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, ] angina, [ atherosclerosis, ] bronchial asthma, [ circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, ] inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, [ arthritis, osteoarthritis, ] fever, cough, cold, [ Alzheimer's disease, ] infection of respiratory tract, [ infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, analeptic, and tranquilizer; haemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; medicinal preparations in tablet form, namely, menstruation circulation regulating tablets; pharmaceutical preparations, namely, for hormone regulation and hormone replacement; ] pharmaceutical preparations for sensory organs, namely, for use in [ ophthalmology, ] otolaryngology [ and dermatology] ; pharmaceutical preparations for regulation and strengthening of the immune system, [ pharmaceutical preparations for treating of and providing temporary relief for occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of medicated balms, medicated dental tapes, medicated dental ribbons, medicated dental polish; pharmaceutical preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays, ] plant extracts for [ veterinary and ] pharmaceutical purposes; [ sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for health purposes; medicated sanitary preparations for the treatment, cleaning and protection of the skin; ] dietary supplements in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form, containing plant extracts; dietetic foods adapted for medical use in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form; [ food for medically restricted diets, food for diabetics, ] food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form; [ vitamin and mineral supplements; food and food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for use in foods and dietary supplements for human consumption; ] dietetic food supplements, dietary supplements, food supplements and dietary food supplements; [ mineral food supplements, food supplements based on amino acids, minerals and/or trace elements, medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectants, material for stopping teeth; dental wax ]

[ Paper; cardboard; goods made from paper and cardboard, namely, paper bags, coasters, and works of art in the nature of art prints; printed matter, namely, books, magazines, journals, newspapers, periodicals, leaflets, manuals, catalogs and brochures in the fields of health and medicine; printed reviews in the nature of a series of written articles in the fields of health and medicine; bookbinding material, namely, book bindings; photographs; stationery; adhesives for stationery or household purposes; artists' materials, namely, artists' pastels, artists' pencils, artists' pens, painting sets for children; paint brushes; typewriters; office requisites except furniture, namely, punches, staplers, erasers, desk pads, pencil sharpeners; instructional and teaching material, namely, printed instructional and teaching material in the field of medicine and phytopharmacy; paper bags, envelopes and pouches for packaging, plastic bags and bubble packs for packaging ]

[ Essential oils for use in the manufacture of cosmetics, hair lotions and perfumery; hair lotions; dentifrices ]

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Aug 1, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 18, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 3, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 9, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 22, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 17, 2023 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Sep 1, 2021 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 15, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Dec 15, 2020 NA71
REGISTERED-SEC.71 ACCEPTED
Dec 15, 2020 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 9, 2020 APRE
TEAS SECTION 71 RECEIVED
Sep 16, 2020 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 2, 2019 REM4
INTERNATIONAL REGISTRATION RENEWED
Apr 11, 2019 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Jan 11, 2018 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 7, 2017 INPS
INVALIDATION PROCESSED
Dec 7, 2017 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 29, 2017 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 29, 2017 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Mar 29, 2017 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 28, 2017 APRE
TEAS SECTION 71 RECEIVED
Oct 12, 2016 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Jun 12, 2014 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 18, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 11, 2011 FICS
FINAL DISPOSITION PROCESSED
Feb 11, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 2, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 2, 2010 R.PR
CHANGE OF OWNER RECEIVED FROM IB
Sep 2, 2010 CHLD
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2010 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 12, 2010 PREV
ASSIGNED TO LIE
Jul 12, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 9, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 9, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 9, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 9, 2010 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 14, 2010 GPRN
PRIORITY ACTION E-MAILED
Jun 14, 2010 GPRA
PRIORITY ACTION WRITTEN
Jun 14, 2010 CPRA
EXAMINER'S AMENDMENT ENTERED
Jun 7, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 7, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 7, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 7, 2010 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2010 CRFA
ASSIGNED TO LIE
May 28, 2010 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2010 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2010 TROA
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
Apr 14, 2010 NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Apr 13, 2010 NAUD
AMENDMENT FROM APPLICANT ENTERED
Mar 26, 2010 ACEC
AMENDMENT FROM APPLICANT ENTERED
Mar 26, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2010 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2010 CRFA
FAX RECEIVED
Mar 24, 2010 FAXX
FAX RECEIVED
Mar 23, 2010 FAXX
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
Feb 26, 2010 NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Feb 26, 2010 NAUD
AMENDMENT FROM APPLICANT ENTERED
Feb 26, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2010 CRFA
ASSIGNED TO LIE
Feb 23, 2010 ALIE
PAPER RECEIVED
Jan 25, 2010 MAIL
REFUSAL PROCESSED BY IB
Oct 3, 2009 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 3, 2009 RFCS
REFUSAL PROCESSED BY MPU
Aug 3, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 1, 2009 RFCR
NON-FINAL ACTION WRITTEN
Jul 31, 2009 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 28, 2009 MAFR
ASSIGNED TO EXAMINER
Jul 24, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2009 NWOS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Jul 23, 2009 LIMS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 23, 2009 REPR